Drug intelligence / Profile preview

chikusetsusaponin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Chikusetsusaponin refers to a group of **oleanane-type triterpenoid saponins** found primarily in several medicinal plants, most notably Panax japonicus and Aralia taibaiensis. The most studied form is *chikusetsusaponin IVa*, but variants include chikusetsusaponin Ib, IV, IVa methyl ester, and Ia. These compounds display a variety of **biological activities**: - **Anticancer:** They inhibit cancer cell proliferation, migration, and invasion (notably via migration/invasion proteins like MMP2, MMP9, and ERK), promote apoptosis mainly through mitochondrial pathways (affecting Caspase-3, Bcl-2, Bax, PARP, Endo G, and AIF), and suppress the IL-6/STAT3 pathway (as an IL-6R antagonist)[1]. - **Anti-inflammatory:** They inhibit inflammation through suppression of the NF-κB and AP-1 signaling pathways, reduce proinflammatory cytokines (TNF-α, IL-1β, IL-6, iNOS, COX-2), downregulate NLRP3 inflammasome, and improve antioxidant defenses by modulating SOD and eNOS activity[1][3][9]. - **Metabolic effects:** Chikusetsusaponin IVa shows promise in obesity, type 2 diabetes, and related conditions by modulating lipid metabolism, reducing insulin resistance, and enhancing insulin signaling, partly through activating AMPK and Wnt/β-catenin/TCF7L2 pathways[4][14]. - **Cell protective effects:** They have documented antioxidant, anticoagulant, and cytoprotective effects, protecting pancreatic β-cells, cardiovascular tissue, and intestinal barriers[4][6][12][1]. They are not pharmaceutical drugs but are studied as **active components in herbal medicines**.

Other names
chikusetsusaponin IVachikusetsusaponin Ibchikusetsusaponin IVa methyl esterchikusetsusaponin Iaginsenoside Rosanchinoside C(1)calenduloside F
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)RELA (Nuclear Factor Kappa B Subunit p65)REN (Renin)YAP1 (YES-associated protein–transcriptional enhancer factor domain complex)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)MEKKDM1A (LSD1)

Beyond the preview

Go deeper on chikusetsusaponin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chikusetsusaponin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call